Skip to main content

Table 1 Baseline Characteristics of the Patients at the initiation of amiodarone infusion

From: Effect of heart rate control with amiodarone infusion on hemodynamic and clinical outcomes in septic shock patients with tachycardia: a prospective, single-arm clinical study

Variable Amiodarone treated patients (n = 46)
Age (year) 59.8 ± 11.3a
Sex (male) 23(50.0)b
BMI (kg/m2) 27.4 ± 3.2
SOFA SCORE 7.24 ± 1.8
PLT (103/μl) 229.9 ± 85.1
BSA (m2) 1.93 ± 0.15
HR (bpm) 118.9 ± 18.7
MAP (mmHg) 98.4 ± 9.3
CI (l/min/m2) 3.61 ± 0.94
SVR (dynes/seconds/cm−5) 1106.8 ± 381.6
SVI (ml/m2/beat) 31.03 ± 8.5
NE (μ/min) 10.74 ± 2.9
FTC (milliseconds) 356.9 ± 78.6
LACTAT (mg/dL) 24.6 ± 11.5
Comorbidities n (%)
 Heart failure 10 (21%)
 Diabetes mellitus 18 (39.1%)
 Chronic kidney disease 13 (28.2%)
 Previous MI 12 (26%)
 Previous stroke 9 (19%)
 Chronic obstructive pulmonary disease 1 (2.2%)
 CRP 13.13 ± 10.59
 GFR (mL/min/1.73 m2) 78.43 ± 16.56
 Cirrhosis 3 (6.5%)
  1. BMI: Body mass index, PLT: platelet, BSA: body surface area, HR: heart rate, MAP: mean arterial pressure, CI: cardiac index, SVR: Systemic vascular resistance, SVI: Stroke Volume Index, NE: Norepinephrine, FTC: flow time corrected, MI: myocardial infarction, CRP: c-reactive protein, GFR: Glomerular Filtration Rate
  2. a Mean ± standard deviation, b number (%)